Article Information
History
- January 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Marwa Amer, PharmD, BCPS, BCCCP, Critical Care Pharmacy Specialista,b,*,†,
- Mohammed Bawazeer, MD, FRCSC, FACS, Trauma & Acute Care Surgery, Consultant Intensivistc,†,
- Khalid Maghrabi, MD, FCCP, MRCP (UK), Consultant Intensivistc,b,
- Rashid Amin, PharmD, BCPS, BCCCP, Critical Care Pharmacy Specialista,
- Edward De Vol, Chairmand and
- Mohammed Hijazi, MD, FACP, FCCP, Consultant Intensivistc
- aPharmaceutical Care Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
- bCollege of Medicine, Alfaisal University
- cDepartment of Critical Care Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
- dDepartment of Biostatistics, Epidemiology, and Scientific Computing, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
- ↵*Corresponding Authors: Marwa Amer PharmD, B.S. Pharm, BCPS, BCCCP
, Email address: mamer{at}kfshrc.edu.sa
↵† Both contributed equally as first Author
Authors contribution MA, MB: conception and design, analytical plan, drafting of the manuscript, critical revision of the manuscript for important intellectual content, approval of the final version to be published and both contributed equally as first Author. KM, RA, MH: acquisition, analysis or interpretation of data, critical revision of the manuscript for important intellectual content, and approval of the final version to be published. ED: performed statistical analysis, revision of the manuscript
Posted January 29, 2021.
Timing and Dose of Pharmacological Thromboprophylaxis in Adult Trauma Patients: Perceptions, Barriers, and Experience of Saudi Arabia Practicing Physicians
